Injectable bulking agents are minimally invasive and have a high recommendation as an early treatment option for fecal incontinence.

Prepare for the Axonics Entrance Test. Practice with flashcards and multiple choice questions featuring detailed explanations and hints, helping you succeed in your exam!

Multiple Choice

Injectable bulking agents are minimally invasive and have a high recommendation as an early treatment option for fecal incontinence.

Explanation:
Management of fecal incontinence relies first on conservative measures, such as dietary adjustments, bowel habit training, pelvic floor muscle exercises, and antidiarrheal or stool-bulk agents. Injectable bulking agents are indeed minimally invasive, but they are not typically recommended as an early treatment option. They’re usually considered after conservative therapies have failed or aren’t suitable, and they often provide only modest, variable durability, sometimes requiring repeat injections. They’re more appropriate for selected patients with a sphincter defect who aren’t candidates for more invasive procedures. So the statement is not correct.

Management of fecal incontinence relies first on conservative measures, such as dietary adjustments, bowel habit training, pelvic floor muscle exercises, and antidiarrheal or stool-bulk agents. Injectable bulking agents are indeed minimally invasive, but they are not typically recommended as an early treatment option. They’re usually considered after conservative therapies have failed or aren’t suitable, and they often provide only modest, variable durability, sometimes requiring repeat injections. They’re more appropriate for selected patients with a sphincter defect who aren’t candidates for more invasive procedures. So the statement is not correct.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy